Effect of tolvaptan on renal involvement in patients with autosomal dominant polycystic kidney disease according to different gene mutations

ConclusionsA year treatment with tolvaptan significantly improved %TKV in patients with ADPKD, regardless of the gene mutation type.
Source: Clinical and Experimental Nephrology - Category: Urology & Nephrology Source Type: research